Solid-tumor CAR-T therapy is limited by antigen escape, heterogeneity, and on-target/off-tumor toxicity. The author here develops a drug-gated light-activatable, programmable CAR-antigen pairing system that enables flexible multi-antigen targeting with spatial control, achieving effective tumor suppression with minimal off-tumor toxicity.
- Ziliang Huang
- Praopim Limsakul
- Yingxiao Wang